ANIP vs GRMN · rev $503.5M vs P/E 28, rev $7.25B
ANI Pharmaceuticals Inc (ANIP) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
ANIP currently screens at market cap $1.41B. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the ANIP and GRMN stock pages for the full models.
Not investment advice.